Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

Todd Neale

September 18, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Michael O'Riordan

February 07, 2025

News Daily News

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

L.A. McKeown

January 21, 2025

News Daily News

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Michael O'Riordan

December 04, 2024

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Todd Neale

December 12, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Autism and Cardiometabolic Disease Often Go Hand in Hand

Caitlin E. Cox

February 06, 2023

News Daily News

Cardiorespiratory Fitness Is Key to Longevity, Regardless of Age, Sex, and Race

Yael L. Maxwell

August 09, 2022

News Daily News

CV Risk Factors, Disease Projected to Explode in Coming Decades

L.A. McKeown

August 01, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

L.A. McKeown

June 16, 2021

News Daily News

Bariatric Surgery Tied to Better Long-term Outcomes After MI

Todd Neale

October 27, 2020

News Daily News

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Caitlin E. Cox

July 15, 2019

News Daily News

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

Michael O'Riordan

October 18, 2018

Advertisement

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

Amylin Analogue Boosts Weight Loss When Added to GLP-1

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

CVD Hospitalization in Older Adults Higher in US Than in Denmark

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Autism and Cardiometabolic Disease Often Go Hand in Hand

Cardiorespiratory Fitness Is Key to Longevity, Regardless of Age, Sex, and Race

CV Risk Factors, Disease Projected to Explode in Coming Decades

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

Bariatric Surgery Tied to Better Long-term Outcomes After MI

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content